None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University Health System, Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Subjects prior to the start of treatment for stages 1 to 4 of various solid carcinomas or healthy adults who have scheduled a cancer medical examination - Men and women over 19 years of age - Subjects and healthy adults who agree to collect and analyze clinical information and human-derived materials for research purposes, and agree to store residual blood samples and use them for secondary research purposes - Subjects who can donate blood without harming their health - Subjects who understand and voluntarily agree to this study
Exclusion criteria
Exclusion criteria: - Subjects under the age of 19 - Vulnerable subjects with mental retardation or severe psychiatric conditions - Subjects who are unable to participate in the study due to other reasons as determined by the researcher - Subjects with a history of HIV, HTLV, and Syphilis infection - Subjects diagnosed with primary unknown cancer or multiple cancers - Subjects diagnosed with other malignant tumor within 5 years(except for non-melanoma skin cancer treated for cure, in-situ disease treated for cure, thyroid cancer, or intraepithelial carcinoma of the cervix)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Developing an analysis platform that can be used for early screening of some cancers | — |
Secondary
| Measure | Time frame |
|---|---|
| Establishing a whole-genome sequencing(circulating DNA in blood) and clinical information database from 1,500 cancer subjects and 500 healthy adults | — |
Countries
Korea, Republic of
Contacts
Public ContactRyeo Choi
SEVERANCE HOSPITAL
Outcome results
None listed